Adherence to post-polypectomy surveillance guidelines: a systematic review and meta-analysis
- PMID: 30909308
- DOI: 10.1055/a-0865-2082
Adherence to post-polypectomy surveillance guidelines: a systematic review and meta-analysis
Abstract
Background: Colorectal cancer (CRC) is a major worldwide cause of cancer-related mortality. Colonoscopy programs based on guideline-recommended surveillance intervals have been put in place to reduce the morbidity and mortality associated with CRC. We were interested to evaluate clinical practice adherence to guideline-recommended surveillance intervals, the potential extent of early repeat colonoscopies, and causes of nonadherence to guideline recommendations.
Methods: We performed a literature search for articles reporting on guideline adherence for surveillance colonoscopies. Exclusion criteria included inflammatory bowel disease and hereditary CRC syndrome cohorts. Primary outcome was correct interval assignment in patients undergoing surveillance colonoscopy. Groups were assessed for adherence according to their respective guideline recommendations (North American or European).
Results: 16 studies were included in the analysis. The mean colonoscopy surveillance interval adherence rate was 48.8 % (95 % confidence interval [CI] 37.3 - 60.4). For North American guidelines, surveillance interval assignments were adherent to guideline recommendations in 44.7 % (95 %CI 24.2 - 66.3) of patients after detection of low risk lesions and in 54.6 % (95 %CI 41.4 - 67.4) after detection of high risk lesions. For European guidelines, surveillance interval assignments were adherent to recommendations in 24.4 % (95 %CI 1.1 - 63.4) of patients after detection of low risk lesions and in 73.6 % (95 %CI 35.5 - 98.8) after detection of high risk lesions.
Conclusions: The worldwide adherence to surveillance colonoscopy guidelines was low, with more than 50 % of patients undergoing repeat colonoscopies either too early or too late. Early repeat colonoscopies occurred with the highest frequency for patients in whom only hyperplastic polyps or low risk adenomas were found.
© Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
Dr. von Renteln is supported by a Fonds de Recherche du Québec Santé career development award; he has also received research funding from ERBE, Ventage, Pendopharm and Pentax, and is a consultant for Boston Scientific and Pendopharm. Dr. Durand is supported by a clinician researcher salary award from the Fonds de recherche du Quebec-Santé.
Comment in
-
Video Comment on Roupen Djinbachian et al.Endoscopy. 2019 Jul;51(7):v19. doi: 10.1055/a-0869-8805. Epub 2019 Jun 27. Endoscopy. 2019. PMID: 31247649 No abstract available.
-
Optimizing post-polypectomy surveillance: when less is more.Endoscopy. 2019 Jul;51(7):615-616. doi: 10.1055/a-0894-4501. Epub 2019 Jun 27. Endoscopy. 2019. PMID: 31247653 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
